Albert Edge

This inventor holds 31 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Hearing Loss Treatment. Top assignees: Massachusetts Eye and Ear Infirmary, The Brigham and Women's Hospital, Inc., University of Southern California. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Albert Edge. Retrieved from https://idiyas.com/inventor/albert-edge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 12)

% Patents Active = 87.1

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 7)

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 67(Granted Patents)

Location History:

Newton, MA (US) (2014 - 2016)
Brookline, MA (US) (2012 - 2023)
Boston, MA (US) (2023)

Company Filing History:

30 out of 276

Massachusetts Eye and Ear Infirmary

patents

5 out of 1,425

The Brigham and Women's Hospital, Inc.

patents

2 out of 1,693

University of Southern California

Decibel Therapeutics, Inc.

patents

6. 1 out of 4,509

Eli Lilly and Company

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Atoh1 Expression

Cochlear Implants

Hair Cell Differentiation

Auditory Hair Cells

Neuroprotection

Stem Cells

Casein Kinase Inhibition

Inner Ear Cells

Reinnervation

Phosphonate-Drug Conjugates

Notch Pathway

Supporting Cells

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12618070 - INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION (2026-05-05),

2. 12502433 - Phosphonate-drug conjugates (2025-12-23),

3. 12427128 - Sensorineural hair cell differentiation (2025-09-30),

4. 12419876 - Treatment of hearing loss by inhibition of casein kinase 1 (2025-09-23),

5. 12161647 - Treating hearing loss (2024-12-10),

6. 11806524 - Bimodal hybrid cochlear implants (2023-11-07),

7. 11542472 - Generation of inner ear cells (2023-01-03),

8. 11466252 - Expansion and differentiation of inner ear supporting cells and methods of use thereof (2022-10-11),

9. 11331391 - Phosphonate-drug conjugates (2022-05-17),

10. 11298328 - Sensorineural hair cell differentiation (2022-04-12),

11. 11286487 - Increasing ATOH1 life to drive sensorineural hair cell differentiation (2022-03-29),

12. 11185536 - Treatment of hearing loss by inhibition of casein kinase 1 (2021-11-30),

13. 11160808 - Compounds that enhance Atoh1 expression (2021-11-02),

14. 11046765 - Methods for promoting reinnervation of auditory hair cells (2021-06-29),

15. 10898492 - Treating hearing loss (2021-01-26),

As a specialized AI assistant in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with the requested article about inventor Albert Edge:

Title: Albert Edge - Pioneering Innovations in Cochlear Implants and Inner Ear Cell Generation

Introduction:

Albert Edge, a renowned inventor based in Brookline, MA (US), has made significant contributions to the field of medical technology. With an impressive portfolio of 26 patents, his groundbreaking work has advanced the development of cochlear implants and inner ear cell generation techniques.

Latest Patents:

Albert Edge's latest patents showcase his innovative approach to improving hearing loss treatment. His inventions include bimodal hybrid cochlear implants, which combine optical and electrical stimulation for enhanced sensitivity. Additionally, his methods for generating inner ear cells from stem cells, and their therapeutic use in treating hearing loss, demonstrate his commitment to revolutionizing auditory healthcare.

Career Highlights:

Throughout his career, Albert Edge has collaborated with prestigious institutions such as the Massachusetts Eye and Ear Infirmary and The Brigham and Women's Hospital, Inc. His expertise and dedication have led to breakthroughs in auditory research, shaping the future of medical interventions for hearing impairments.

Collaborations:

Albert Edge has collaborated with esteemed colleagues in his field, including Sang-Jun Jeon and Kathleen Seyb. Together, they have worked tirelessly to push the boundaries of cochlear implant technology and inner ear cell regeneration, garnering recognition for their impactful contributions to the medical community.

Conclusion:

In conclusion, Albert Edge stands out as a trailblazing inventor in the realm of cochlear implants and inner ear cell generation. His unwavering passion for innovation and commitment to advancing treatment options for hearing loss have established him as a leading figure in the field. Through his pioneering work, Albert Edge continues to inspire progress and transform the landscape of auditory healthcare.

Profile summary based on public USPTO records.